TOBIN JAMES R
Director
SaleAlert
- Shares
- 30,000
- Price
- $74.58
- Value
- $2,237,502
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•35 filings
GMED
GLOBUS MEDICAL INC
Net sales of $4.4M over the last 3 months
2 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$4,413,467
0 buyers · 2 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$17,539,235
7 distinct insiders
Highlighted alerts
5
10 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get GMED insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
GMED overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
65
Raw transactions
Everything returned by the filing
15
Voluntary view
P/S trades after deterministic checks
50
Administrative noise
Stored, never alerted
26
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- M
- Shares
- 15,000
- Price
- $63.68
- Footnotes
- 3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.33 to $74.96, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. These options were granted on January 26, 2024 and are fully vested. These options were granted on January 27, 2022 and are fully vested.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
ZARRILLI STEPHEN T
Director
SaleAlert
- Shares
- 25,000
- Price
- $87.04
- Value
- $2,175,965
Davidar David D
Director
SaleAlert
- Shares
- 25,000
- Price
- $80.76
- Value
- $2,019,073
Huller Kelly
EVP, GC, Corporate Secretary
Sale 10b5-1
- Shares
- 20,000
- Price
- $94.50
- Value
- $1,890,000
Huller Kelly
EVP, GC, Corporate Secretary
Sale 10b5-1
- Shares
- 10,000
- Price
- $87.67
- Value
- $876,700
Kline Kyle
Senior Vice President, CFO
Sale 10b5-1
- Shares
- 3,594
- Price
- $101.10
- Value
- $363,353
Norwalk Leslie V
Director
Sale 10b5-1
- Shares
- 2,000
- Price
- $101.10
- Value
- $202,200
Norwalk Leslie V
Director
Sale 10b5-1
- Shares
- 4,000
- Price
- $88.85
- Value
- $355,400
Kline Kyle
Senior Vice President, CFO
Sale 10b5-1
- Shares
- 18,542
- Price
- $90.00
- Value
- $1,668,780
Huller Kelly
SVP, GC, Corporate Secretary
Sale 10b5-1
- Shares
- 7,500
- Price
- $90.00
- Value
- $675,000
Davidar David D
Director
SaleAlert
- Shares
- 25,000
- Price
- $86.00
- Value
- $2,150,005
ZARRILLI STEPHEN T
Director
SaleAlert
- Shares
- 25,000
- Price
- $84.29
- Value
- $2,107,258
RHOADS ANN D
Director
Sale 10b5-1
- Shares
- 2,000
- Price
- $85.00
- Value
- $170,000
RHOADS ANN D
Director
Sale 10b5-1
- Shares
- 8,000
- Price
- $81.00
- Value
- $648,000
RHOADS ANN D
Director
Sale 10b5-1
- Shares
- 10,000
- Price
- $58.46
- Value
- $584,600
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | TOBIN JAMES R Director | Sale | 30,000 | $74.58 | $2,237,502 | |
| Aug 18, 2026 | ZARRILLI STEPHEN T Director | Sale | 25,000 | $87.04 | $2,175,965 | |
| Jun 05, 2026 | Davidar David D Director | Sale | 25,000 | $80.76 | $2,019,073 | |
| Feb 25, 2026 | Huller Kelly EVP, GC, Corporate Secretary | Sale | 20,000 | $94.50 | $1,890,000 | |
| Feb 12, 2026 | Huller Kelly EVP, GC, Corporate Secretary | Sale | 10,000 | $87.67 | $876,700 | |
| Jan 08, 2026 | Kline Kyle Senior Vice President, CFO | Sale | 3,594 | $101.10 | $363,353 | |
| Jan 08, 2026 | Norwalk Leslie V Director | Sale | 2,000 | $101.10 | $202,200 | |
| Dec 12, 2025 | Norwalk Leslie V Director | Sale | 4,000 | $88.85 | $355,400 | |
| Dec 01, 2025 | Kline Kyle Senior Vice President, CFO | Sale | 18,542 | $90.00 | $1,668,780 | |
| Nov 25, 2025 | Huller Kelly SVP, GC, Corporate Secretary | Sale | 7,500 | $90.00 | $675,000 | |
| Nov 12, 2025 | Davidar David D Director | Sale | 25,000 | $86.00 | $2,150,005 | |
| Nov 11, 2025 | ZARRILLI STEPHEN T Director | Sale | 25,000 | $84.29 | $2,107,258 | |
| Nov 10, 2025 | RHOADS ANN D Director | Sale | 2,000 | $85.00 | $170,000 | |
| Nov 07, 2025 | RHOADS ANN D Director | Sale | 8,000 | $81.00 | $648,000 | |
| Sep 15, 2025 | RHOADS ANN D Director | Sale | 10,000 | $58.46 | $584,600 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.